Bayocot, Lani P.
HRN: 23-69-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/19/2024
01/25/2024
IV
2.25g
Q6H
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes